EUVIMEDEUVIMED entdecken
Crossref

COVID-19 Outcomes Among People With HIV and COVID-19 in New York City

Sarah L Braunstein iD, Amanda Wahnich, Rachael Lazar

The Journal of Infectious Diseases · 2023

DOI: 10.1093/infdis/jiad311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Sarah L Braunstein und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bureau of Hepatitis, HIV, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, Long Island City, New York, USA. Hauptthemen laut MEDLINE: COVID-19, HIV Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Literature on the impact of human immunodeficiency virus (HIV) on coronavirus disease 2019 (COVID-19)–related outcomes remains mixed. Few studies have evaluated COVID-19 outcomes by HIV status using population-based data.

Methods

Using data from New York City COVID-19 surveillance and HIV surveillance systems prior to the widespread availability of COVID-19 vaccines, we conducted a retrospective cohort study comparing the risk of COVID-19 hospitalization and mortality by HIV status among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnoses from 29 February to 17 October 2020.

Results

Risk of hospitalization and death among people with HIV (PWH) withCOVID-19 were both nearly 30% higher compared with people without HIV. In crude models, incidence of adverse COVID-19 outcomes among PWH compared to people without HIV was elevated in certain groups, including women, and black, Hispanic/Latino, Native American, and multiracial people. CD4 cell count at SARS-CoV-2 diagnosis and presence of an underlying, non-HIV–related condition were independently and strongly associated with risk for COVID-19 hospitalization and death among PWH.

Conclusions

New Yorkers with HIV experienced elevated risk for poor COVID-19 outcomes compared to those without HIV during 2020. PWH, particularly those with low CD4 counts or underlying conditions, should be an ongoing focus for COVID-19 vaccination and rigorous identification and treatment of SARS-CoV-2 infections to prevent adverse outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HIV InfectionsHumansFemaleCOVID-19 VaccinesSARS-CoV-2COVID-19 TestingNew York CityRetrospective Studies

Stichwörter der Autor:innen

COVID-19HIVhospitalizationmortalitypopulation-level surveillance

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Bureau of Hepatitis, HIV, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, Long Island City, New York, USA.

ORCID-Profile: Sarah L Braunstein

Förderung

  • CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Braunstein, S. L., Wahnich, A., & Lazar, R. (2023). COVID-19 Outcomes Among People With HIV and COVID-19 in New York City. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad311

Vancouver

Braunstein SL, Wahnich A, Lazar R. COVID-19 Outcomes Among People With HIV and COVID-19 in New York City. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad311

BibTeX
@article{Braunstein2023,
  author = {Braunstein, Sarah L and Wahnich, Amanda and Lazar, Rachael},
  title = {COVID-19 Outcomes Among People With HIV and COVID-19 in New York City},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1093/infdis/jiad311}
}
Kostenlos starten →